Episurf acquires properties with an agreed property value of MSEK 897 from KlaraBo

Episurf agreed to acquire a 164-property portfolio from KlaraBo with an underlying agreed property value of MSEK 897 and a preliminary purchase price of approximately MSEK 361 (after a 5.15% deferred latent capital gains tax deduction). Payment is via two promissory notes (MSEK 231 repayable over two-to-three years; MSEK 130 to be offset through a directed issue of up to 2,888,888,888 series B shares at SEK 0.045 each, implying up to 65.1% immediate dilution), and KlaraBo will provide a potential cash loan to cover funding shortfalls; the portfolio yields approx. MSEK 73.4 in annual rental income and total lettable area ~57,250 m2 (book value ~MSEK 913 as of 30 Sep 2025). Closing is conditional on approval by the Swedish Inspectorate for Strategic Products, securing external financing and a shareholder resolution to amend the company’s articles, with completion expected in H1 2026.

Analysis

Market structure: Episurf's pivot concentrates downside on EPIS B holders while directly benefiting KlaraBo (seller) via sizeable equity consideration and cash loan support. The acquisition effectively transfers a ~MSEK 73.4 recurring rental stream onto a sub-MSEK 361 purchase price (implied gross yield ~20%), signalling a potential arbitrage if assets are revalued on Episurf's balance sheet—but only if financing and approvals clear. For Swedish real-estate incumbents (Balder BALD B, Hemsö HMSO) the deal increases comparative visibility for high-yield residential assets and may compress cap-rate dispersion in small-cap REITs.

Risk assessment: Immediate risks: dilution (up to 65% in worst case) and general-meeting approval on 10-Apr-2026; regulatory blocking by the Swedish Inspectorate (SvP) or failure to secure external financing are 20–40% probability tail events that would crash EPIS B. Short-term (weeks–months) operational risks include integration, lease roll risk in Bollnäs/Trelleborg and latent tax adjustments; long-term risks include property price cyclicality (≥20% downside in a recession) and management credibility loss. Hidden dependency: success hinges on Episurf converting from medtech to property operator—skill set and working capital mismatch create execution risk.

Trade implications: Tactical short EPIS B ahead of the General Meeting and SvP decision (size 2–3% NAV, target 30–50% downside, stop-loss +15% above entry, horizon 1–3 months). Long selective Swedish residential landlords (BALD B, HMSO) 2–4% each for 6–18 months to capture cap-rate re-rating; consider pair trade long HMSO / short EPIS B to isolate sector vs idiosyncratic risk. Use options: buy EPIS B puts or put spreads expiring Jun–Sep 2026 to cap risk; sell covered calls on long REIT positions to enhance yield.

Key Decisions for Investors

• Establish a short position in EPIS B (Episurf Medical) sized 2–3% of portfolio NAV ahead of the General Meeting (10-Apr-2026) and SvP decision; set target 30–50% downside within 1–3 months, stop-loss at +15% to limit blow-up risk.
• Initiate 2–4% long positions in Swedish residential landlords BALD B (Balder) and HMSO (Hemsö) with 6–18 month horizon to capture relative rerating of high-quality income-generating housing assets; average-in on any 10% pullbacks.
• Execute a pair trade: long HMSO (2% NAV) / short EPIS B (2% NAV) to isolate real-estate beta from Episurf idiosyncratic execution risk; rebalance after SvP decision.
• Buy EPIS B put spreads (expires Jun–Sep 2026) as cheaper downside protection if options liquidity allows; alternatively buy outright deep-OTM puts sized to cap downside to 1% NAV. Monitor three catalysts before adding risk: (a) SvP ruling (expected H1 2026), (b) General Meeting on 10-Apr-2026, (c) confirmation of external financing within 60 days; reduce positions if any catalyst is missed.